https://orcid.org/0000-0003-0553-4039
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Elisabeth Prevete, Valeria Catalani, Darshan Singh, Kim P. C. Kuypers, Eef L. Theunissen, Honor D. Townshend, Hani Banayoti, Johannes G. Ramaekers, Massimo Pasquini & Ornella Corazza. (2023) A Preliminary Inventory of Kratom (Mitragyna Speciosa) Products and Vendors on the Darknet and Cryptomarkets. Journal of Psychoactive Drugs 0:0, pages 1-11.
Read now
Read now
Alexandra Arenson, Cynthia I. Campbell & Ilan Remler. (2023) Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder – a narrative review. Journal of Addictive Diseases 0:0, pages 1-11.
Read now
Read now
Oliver Grundmann, Charles A. Veltri, Diana Morcos, David Knightes$suffix/text()$suffix/text(), Kirsten E. Smith & Jeffery M. Rogers. (2022) How essential is kratom availability and use during COVID-19? Use pattern analysis based on survey and social media data. Substance Abuse 43:1, pages 865-877.
Read now
Read now
Articles from other publishers (18)
Maximilian Gahr. (2022) Kratom (Mitragyna speciosa): eine psychoaktive Pflanze mit Chancen
und Risiken. Fortschritte der Neurologie · Psychiatrie 91:11, pages 455-465.
Crossref
Crossref
Mary Ann Faucher, Stephanie Morillos, Polly Cordova, Jessica McNeil‐Santiel, Nancy Onisko, Emily H. Adhikari & David B. Nelson. (2023)
Kratom (
Mitragyna speciosa
): A Case Review of Use Before and During Pregnancy
. Journal of Midwifery & Women's Health.
Crossref
Crossref
Jack E. Henningfield, Marek C. Chawarski, Albert Garcia-Romeu, Oliver Grundmann, Norsyifa Harun, Zurina Hassan, Christopher R. McCurdy, Lance R. McMahon, Abhisheak Sharma, Mohammed Shoaib, Darshan Singh, Kirsten E. Smith, Marc T. Swogger, Balasingam Vicknasingam, Zachary Walsh, Daniel W. Wang & Marilyn A. Huestis. (2023) Kratom withdrawal: Discussions and conclusions of a scientific expert forum. Drug and Alcohol Dependence Reports 7, pages 100142.
Crossref
Crossref
Donna Papsun, William SchroederIIII, Justin Brower & Barry Logan. (2023) Forensic Implications of Kratom: Kratom Toxicity, Correlation with Mitragynine Concentrations, and Polypharmacy. Current Addiction Reports 10:2, pages 272-281.
Crossref
Crossref
Larissa C. Laforest, Michelle A. Kuntz, Siva Rama Raju Kanumuri, Sushobhan Mukhopadhyay, Abhisheak Sharma, Sarah E. O’Connor, Christopher R. McCurdy & Satya Swathi Nadakuduti. (2023)
Metabolite and Molecular Characterization of
Mitragyna speciosa
Identifies Developmental and Genotypic Effects on Monoterpene Indole and Oxindole Alkaloid Composition
. Journal of Natural Products 86:4, pages 1042-1052.
Crossref
Crossref
Kirsten Elin Smith, Jeffrey M. Rogers & Jeffrey D. Feldman. (2023) Kratom’s Emergence and Persistence Within the US Polydrug Epidemic. Current Addiction Reports 10:2, pages 262-271.
Crossref
Crossref
Sushobhan Mukhopadhyay, Sampa Gupta, Jenny L. Wilkerson, Abhisheak Sharma, Lance R. McMahon & Christopher R. McCurdy. (2023) Receptor Selectivity and Therapeutic Potential of Kratom in Substance Use Disorders. Current Addiction Reports 10:2, pages 304-316.
Crossref
Crossref
David Peran, Michael Stern, Petr Cernohorsky, Roman Sykora, Stanislav Popela & Frantisek Duska. (2023) Mitragyna speciosa (Kratom) poisoning: Findings from ten cases. Toxicon 225, pages 107054.
Crossref
Crossref
Kirsten Elin Smith, Abhisheak Sharma, Oliver Grundmann & Christopher R. McCurdy. (2023) Kratom Alkaloids: A Blueprint?. ACS Chemical Neuroscience 14:2, pages 195-197.
Crossref
Crossref
Corneliu N. Stanciu, Samantha A. Gnanasegaram, Gerald L. RaderIIIIII, Abhisheak Sharma & Christopher R. McCurdy. (2023) What Is the Kratom Overdose Risk? A Systematic Literature Review. Current Addiction Reports 10:1, pages 9-28.
Crossref
Crossref
Emily H. Garmon & Kandice Olson. (2022) Narrative Review of Kratom, an Emerging Psychoactive Substance With Perianesthetic Implications. Anesthesia & Analgesia 135:6, pages 1180-1188.
Crossref
Crossref
Jack E. Henningfield, Joseph V. Rodricks, Aaron M. Magnuson & Marilyn A. Huestis. (2022) Respiratory effects of oral mitragynine and oxycodone in a rodent model. Psychopharmacology 239:12, pages 3793-3804.
Crossref
Crossref
Nisa Leksungnoen, Tushar Andriyas, Chatchai Ngernsaengsaruay, Suwimon Uthairatsamee, Phruet Racharak, Weerasin Sonjaroon, Roger Kjelgren, Brian J. Pearson, Christopher R. McCurdy & Abhisheak Sharma. (2022) Variations in mitragynine content in the naturally growing Kratom (Mitragyna speciosa) population of Thailand. Frontiers in Plant Science 13.
Crossref
Crossref
Mengzi Zhang, Abhisheak Sharma, Francisco León, Bonnie Avery, Roger Kjelgren, Christopher R. McCurdy & Brian J. Pearson. (2022) Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance. PLOS ONE 17:4, pages e0259326.
Crossref
Crossref
Norsyifa Harun, Nur Azzalia Kamaruzaman, Zarif Mohamed Sofian & Zurina Hassan. (2022) Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy. Neuroscience Letters 773, pages 136500.
Crossref
Crossref
Erin C. Berthold, Shyam H. Kamble, Kanumuri S. Raju, Michelle A. Kuntz, Alexandria S. Senetra, Marco Mottinelli, Francisco León, Luis F. Restrepo, Avi Patel, Nicholas P. Ho, Takato Hiranita, Abhisheak Sharma, Lance R. McMahon & Christopher R. McCurdy. (2022) The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic Study. Drug Metabolism and Disposition 50:2, pages 158-167.
Crossref
Crossref
Jack E. Henningfield, Daniel W. Wang & Marilyn A. Huestis. (2022) Kratom Abuse Potential 2021: An Updated Eight Factor Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
Walter C. Prozialeck, Peter C. Lamar, Michael KruppIIII, Matthew Moon, Laura E. Phelps & Oliver Grundmann. (2021) Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States. Frontiers in Pharmacology 12.
Crossref
Crossref